Targeting cannabinoid agonists for inflammatory and neuropathic pain

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.16, Iss.7, 2007-07, pp. : 951-965

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Analgesic and antiinflammatory effects of cannabinoid receptor agonists in a rat model of neuropathic pain

By Leichsenring Anna

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 379, Iss. 6, 2009-06 ,pp. : 627-636

Springer Publishing Company

Access to resources Recommend Favorite

Targeting Voltage-Gated Sodium Channels for Treating Neuropathic and Inflammatory Pain

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 10, 2011-10 ,pp. : 1715-1719

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Melatonin MT2 Receptors: A Novel Pharmacological Avenue for Inflammatory and Neuropathic Pain

Current Medicinal Chemistry, Vol. 25, Iss. 32, 2018-10 ,pp. : 3866-3882

Bentham Science Publishers

Access to resources Recommend Favorite

Cannabinoid CB 1 receptor upregulation in a rat model of chronic neuropathic pain

By Siegling A. Hofmann H.A. Denzer D. Mauler F. De Vry J.

European Journal of Pharmacology, Vol. 415, Iss. 1, 2001-03 ,pp. : 5-7

Elsevier

Access to resources Recommend Favorite

Small Molecules Targeting the NMDA Receptor Complex as Drugs for Neuropathic Pain

Mini Reviews in Medicinal Chemistry, Vol. 3, Iss. 7, 2003-11 ,pp. : 749-756

Bentham Science Publishers

Access to resources Recommend Favorite